Biotechnology
Healthcare
Technology
Advaxis
$0.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.012 (-2.44%) Today
+$0.02 (4.17%) After Hours
Why Robinhood?
You can buy or sell Advaxis and other stocks, options, ETFs, and crypto commission-free!
About
Advaxis, Inc. Common Stock, also called Advaxis, is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. Read More It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.
CEO
Employees
58
Headquarters
Princeton, New Jersey
Founded
1987
Market Cap
34.31M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
869.20K
High Today
$0.50
Low Today
$0.443
Open Price
$0.50
Volume
1.15M
52 Week High
$2.04
52 Week Low
$0.181
Collections
Biotechnology
Healthcare
Technology
Health
Cancer Prevention
Medical
Therapy
2013 IPO
News
Yahoo Finance12h
Has Advaxis (ADXS) Outpaced Other Medical Stocks This Year?
ONE Gas (OGS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Investors focused on the Medical space have likely heard of Advaxis (ADXS), but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out. Advaxis is one of 833 companies in the Medical group. The Medical group currently sits at #3 within the Zacks Sector Rank. The Zacks Sector Rank gauges...
Yahoo FinanceMar 13
These Four Healthcare Stocks Are Making Moves on Wednesday
CORAL GABLES, FL / ACCESSWIRE / March 13, 2019 / The healthcare stock market has managed to attract significant attention in the initial months of 2019 as a result of healthcare companies demonstrating to investors and consumers their commitment to the future of the industry.
Yahoo FinanceMar 12
Advaxis: Fiscal 1Q Earnings Snapshot
PRINCETON, N.J. (AP) _ Advaxis Inc. (ADXS) on Tuesday reported fiscal first-quarter net income of $12.8 million, after reporting a loss in the same period a year earlier. On a per-share basis, the Princeton, New Jersey-based company said it had profit of 18 cents. Earnings, adjusted for non-recurring gains, came to 15 cents per share. The biotechnology company posted revenue of $19.7 million in the period. The company's shares closed at 33 cents. A year ago, they were trading at $2.20. _____ This story...
Price Paid on Robinhood
33% Lower
Right Now
52 Week Low
$0.181
Average Price Paid
$0.7417
52 Week High
$2.04
Earnings
-$0.80
-$0.55
-$0.29
-$0.04
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.25 per share
Actual
-$0.04 per share